Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000945598 | SCV000715086 | likely benign | not provided | 2018-04-16 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26096313) |
Labcorp Genetics |
RCV000945598 | SCV001091634 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001152543 | SCV001313761 | uncertain significance | Joubert syndrome 17 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV000945598 | SCV001334716 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | CPLANE1: BP4, BS2 |
Revvity Omics, |
RCV000945598 | SCV003829940 | uncertain significance | not provided | 2022-06-13 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000945598 | SCV001797743 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000945598 | SCV001968947 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003927959 | SCV004752488 | benign | CPLANE1-related disorder | 2019-07-10 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |